← FDA DRUG APPROVALS

FDA NDA · NDA020686

LUMENHANCE

Sponsor: BRACCO

APPLICATION
NDA020686
TYPE
NDA
ORIGINAL APPROVAL
1997-12-19
LATEST ACTION
1997-12-19
ROUTE
ORAL
DOSAGE FORM
FOR SOLUTION
MARKETING STATUS
Discontinued

Products

LUMENHANCEDiscontinued
MANGANESE CHLORIDE TETRAHYDRATE 3.49MG/GM · FOR SOLUTION · ORAL

Approval history

1997-12-19Type 3 - New Dosage Form · Original · standardAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →